Deadly Ebola virus on the brink of being tamed
Preliminary analysis of 499 Ebola infected participants has sprung a surprise — the chances of survival may be as high as 90% if patients are treated with one of the…
Category: Ebola
Merck’s unlicensed Ebola vaccine shows 97.5% efficacy in Congo
Merck’s Ebola vaccine, which underwent phase-3 trial during the 2014-2015 Ebola epidemic in west Africa, has shown 97.5% efficacy in preventing Ebola disease when used during the current epidemic in…
WHO declares Ebola in Congo as public health emergency
On July 17, the WHO finally declared Ebola virus disease outbreak in Congo a Public Health Emergency of International Concern. Since the beginning of the outbreak in August 2018, Ebola…
Can Congo again swiftly control Ebola spread, death?
Days after the WHO declared the end of the May 8 Ebola outbreak in the Democratic Republic of the Congo, a fresh outbreak was reported on August 1 in North Kivu. If…
Top health stories of 2016
On the health front, the year 2016 witnessed a few setbacks and but also a few positive developments. Here are the most important health developments of 2016 1. Trial results…
Vaccine trial for Zika virus to start soon in humans
The first Phase-1 human clinical trial of a vaccine for Zika virus is set to begin in the coming weeks, with the U.S. Food and Drug Administration (FDA) green-lighting it. The…
Novel approaches to fight Aedes aegypti mosquito
An estimated 390 million dengue infections occurring each year across 150-odd countries is proof that the current mosquito control measures are grossly inadequate to keep the Aedes species, the vector…
Editorial: Gearing up for the Zika threat
The World Health Organization has declared that the outbreak of Zika and congenital malformations and neurological disorders in newborns believed to be connected to the virus is a global public…
